Verrelli, D.; Dallera, L.; Stendardo, M.; Monzani, S.; Pasqualato, S.; Giorgio, M.; Pallavi, R.
Hydroxycitric Acid Inhibits Chronic Myelogenous Leukemia Growth through Activation of AMPK and mTOR Pathway. Nutrients 2022, 14, 2669.
https://doi.org/10.3390/nu14132669
AMA Style
Verrelli D, Dallera L, Stendardo M, Monzani S, Pasqualato S, Giorgio M, Pallavi R.
Hydroxycitric Acid Inhibits Chronic Myelogenous Leukemia Growth through Activation of AMPK and mTOR Pathway. Nutrients. 2022; 14(13):2669.
https://doi.org/10.3390/nu14132669
Chicago/Turabian Style
Verrelli, Doriana, Luca Dallera, Massimo Stendardo, Silvia Monzani, Sebastiano Pasqualato, Marco Giorgio, and Rani Pallavi.
2022. "Hydroxycitric Acid Inhibits Chronic Myelogenous Leukemia Growth through Activation of AMPK and mTOR Pathway" Nutrients 14, no. 13: 2669.
https://doi.org/10.3390/nu14132669
APA Style
Verrelli, D., Dallera, L., Stendardo, M., Monzani, S., Pasqualato, S., Giorgio, M., & Pallavi, R.
(2022). Hydroxycitric Acid Inhibits Chronic Myelogenous Leukemia Growth through Activation of AMPK and mTOR Pathway. Nutrients, 14(13), 2669.
https://doi.org/10.3390/nu14132669